The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs Evidence from a 2011 Agency for Healthcare Research and Quality systematic review primarily informs this PCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results